Lisa R. Sammaritano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Latest Publications
- 1 August 2013
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 19 (5) , 259-266
Pregnancy in Rheumatic Disease Patients
- 1 August 2013
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 19 (5) , 259-266
Pregnancy in Rheumatic Disease Patients
- 1 May 2012
- Published by Elsevier in Autoimmunity Reviews
- Vol. 11 (6-7) , A430-A436
Menopause in patients with autoimmune diseases
- 1 May 2012
- Published by Elsevier in Autoimmunity Reviews
- Vol. 11 (6-7) , A430-A436
Menopause in patients with autoimmune diseases
- 30 November 2010
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 36 (4) , 729-740
Rheumatologic Manifestations of Pregnancy
- 30 November 2010
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 36 (4) , 729-740
Rheumatologic Manifestations of Pregnancy
- 4 September 2007
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 3 (10) , 548-549
Is treatment with tumor necrosis factor inhibitors safe in pregnant patients?
- 4 September 2007
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 3 (10) , 548-549
Is treatment with tumor necrosis factor inhibitors safe in pregnant patients?
- 1 May 2007
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 3 (5) , 273-281
Therapy Insight: guidelines for selection of contraception in women with rheumatic diseases
Ature Clinical Practice Oncology will deliver timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief and international Advisory Board will ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of Nature Publishing Group.
- 1 May 2007
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 3 (5) , 273-281
Therapy Insight: guidelines for selection of contraception in women with rheumatic diseases
Ature Clinical Practice Oncology will deliver timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief and international Advisory Board will ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of Nature Publishing Group.
- 1 June 2005
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 98 (6) , 617-625
Antiphospholipid Syndrome: Review
Antiphospholipid syndrome spans many medical disciplines. Classic criteria include the presence of anticardiolipin antibody or lupus anticoagulant with typical complications of thrombosis or pregnancy loss. Other common associated manifestations include livedo reticularis, thrombocytopenia, valvular heart disease, and nephropathy with renal insufficiency, hypertension, and proteinuria. Treatment...
- 1 June 2005
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 98 (6) , 617-625
Antiphospholipid Syndrome: Review
Antiphospholipid syndrome spans many medical disciplines. Classic criteria include the presence of anticardiolipin antibody or lupus anticoagulant with typical complications of thrombosis or pregnancy loss. Other common associated manifestations include livedo reticularis, thrombocytopenia, valvular heart disease, and nephropathy with renal insufficiency, hypertension, and proteinuria. Treatment...
- 1 June 2001
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 3 (3) , 213-221
Update on the management of the pregnant patient with antiphospholipid antibody
Management of the pregnant patient with antiphospholipid antibody (aPL) is reviewed, with emphasis on recent randomized controlled clinical trials. These support the use of subcutaneous heparin and low dose aspirin, current standard therapy for women with aPL and a history of fetal loss. Prednisone is rarely used due to high risk of maternal and fetal morbidity. Intravenous immunoglobulin may represent an important additional therapy for women who fail aspirin and heparin. Patients with a history of thrombosis require full, therapeutic anticoagulation during pregnancy. Recommendations are less clear for newly described antibodies to phospholipid-binding protein, for low titer antibodies, and for infertility treatment in the setting of aPL.
- 1 June 2001
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 3 (3) , 213-221
Update on the management of the pregnant patient with antiphospholipid antibody
Management of the pregnant patient with antiphospholipid antibody (aPL) is reviewed, with emphasis on recent randomized controlled clinical trials. These support the use of subcutaneous heparin and low dose aspirin, current standard therapy for women with aPL and a history of fetal loss. Prednisone is rarely used due to high risk of maternal and fetal morbidity. Intravenous immunoglobulin may represent an important additional therapy for women who fail aspirin and heparin. Patients with a history of thrombosis require full, therapeutic anticoagulation during pregnancy. Recommendations are less clear for newly described antibodies to phospholipid-binding protein, for low titer antibodies, and for infertility treatment in the setting of aPL.